Ella Therapeutics is developing microbiome-based products for combination therapy with immuno-oncology. Ella Therapeutics' mission is to overcome immunotherapy resistance in cancer patients through alteration of the gut microbiome via engineered bacteria or a live biotherapeutic product. The company's platform is for all major cancer indications and was developed with the aim of saving lives that were otherwise lost due to patients' bodies' resistance to medicine.